The largest community of pharma leaders

Jack Nathan Health Launches Telemedicine in Mexico

TORONTO–()–Jack Nathan Medical Corp. (TSXV:JNH) (“Jack Nathan Health®” “JNH” or the “Company”) a provider of primary care medical clinics located in Walmart® Supercentres under the Jack Nathan Health brand, today announced that its wholly-owned subsidiary, Jack Nathan Health Mexico launched a nationwide telemedicine service portal.

“Our telemedicine service portal expands access to primary health care in Mexico. It is an affordable way for everyday patients to maintain accurate medical monitoring, manage chronic diseases, and proactively identify health risk factors. The launch of our telemedicine portal in Mexico is a major technology step forward for Jack Nathan’s Circle of Health Care vision,” said George Barakat CEO & Co-Founder of Jack Nathan Health.

“Jack Nathan Health has built a trusted reputation in Mexico through their clinics conveniently located in Walmart and Superama locations. Our expansion into telemedicine will positively impact the way patients in Mexico interact with their doctors,” said Laura Camacho, Country Manager of Jack Nathan Health Mexico. “The opportunity to see and interact with a physician from the comfort of your home or office, is very new for Mexico and will open up much needed access to physicians nationally, while lowering costs to patients. This will connect patients to physicians like never before, and ultimately lead to better health outcomes. The people of Mexico needed a telemedicine partner with high-quality virtual physicians. Jack Nathan Health is now that trusted partner for all citizens and families in Mexico.”

Jack Nathan Health’s telemedicine service is available for patients nationwide and can be reached through https://www.jacknathanhealth.com/covid-19-mx. The friendly interface is accessible from any device and will allow you to schedule a telemedicine appointment with one of our Jack Nathan Health doctors located in Mexico. Our telemedicine portal is exclusive to our Jack Nathan Health Mexico physicians. Clinics within Walmart and Superama Mexico are run by Jack Nathan Health Mexico, employing the physicians, nurses, and support staff and are fully owned and operated by Jack Nathan Health.

In addition to telemedicine services, Jack Nathan Health Mexico located within Walmart and Superama stores, offers walk-in clinics with personalized care, lab tests, visual care, dental plan, family planning, corporate health and chronic disease monitoring programs. Our patient-centric model in Mexico allows the patient to develop close relationships with their physicians and create personal health care plans for families to “Live your Best Life.”

Jack Nathan Health Mexico started operations in 2017 and has worked tirelessly to positively impact the ways Mexican citizens approach primary care services. Currently Jack Nathan Health Mexico operates six clinics located within Walmart Mexico brands, and is working to develop and extensive nationwide rollout.

For more information about the locations in Mexico and special offers follow us in social media:

Facebook: Jack Nathan Health Mexico

Instagram: jnhmexico

About Jack Nathan Medical Corp.

Jack Nathan Medical Corp., operating as Jack Nathan Health®, is one of Canada’s largest healthcare networks. Jack Nathan Health is an innovative healthcare company that is improving access for millions of patients by co-locating physician and ancillary medical services conveniently located inside Walmart® stores.

Jack Nathan Health provides an exceptional level of patient care, made possible through patient-centric physicians, a variety of medical services, technology, and programs, designed to put patients first. Our mission is to provide everyone access to the finest quality retail medical centres, with both in-clinic physicians and digital telemedicine, so you and your loved ones can “Live Your Best Life”.

Jack Nathan Health was established in 2006 and continues to expand its international footprint, delivering exceptional, state-of-the-art, turn-key medical centres in 76 Walmart locations across Canada including British Columbia, Alberta, Saskatchewan, Manitoba, Ontario and Quebec, as well as six locations in Mexico.

For more information, visit www.jacknathanhealth.com or www.sedar.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Certain statements contained in this press release constitute “forward-looking information” as such term is defined in applicable Canadian securities legislation. The words “may”, “would”, “could”, “should”, “potential”, “will”, “seek”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” and similar expressions as they relate to Jack Nathan are intended to identify forward-looking information. All statements other than statements of historical fact may be forward-looking information. Such statements reflect the Company’s current views and intentions with respect to future events, and current information available to them, and are subject to certain risks, uncertainties and assumptions Many factors could cause the actual results, performance or achievements that may be expressed or implied by such forward-looking information to vary from those described herein should one or more of these risks or uncertainties materialize. Such factors include but are not limited to: changes in economic conditions or financial markets; increases in costs; litigation; legislative and other judicial, regulatory, political and competitive developments; the economic and business impact of Covid19 and operational difficulties. This list is not exhaustive of the factors that may affect forward-looking information. These and other factors should be considered carefully, and readers should not place undue reliance on such forward-looking information. Should any factor affect the Company in an unexpected manner, or should assumptions underlying the forward-looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, the Company does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking information included in this press release is made as of the date of this press release and the Company undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law.

Recent Articles

Reven Pharmaceuticals Reports on the Importance of Micronutrients and Vitamins for COVID-19 in a Prestigious Medical Journal

GOLDEN, Colo.--(BUSINESS WIRE)--Reven Holdings, Inc. (“Reven”), a privately held clinical stage biotechnology and pharmaceutical company dedicated to the discovery and development of novel treatment...

Anthony Welters Joins Gilead Sciences’ Board of Directors

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that Anthony Welters has been appointed to the company’s Board of Directors. Mr. Welters retired...

AVIA Names Linda Finkel as CEO

CHICAGO--(BUSINESS WIRE)--AVIA, the nation’s leading digital transformation partner for healthcare organizations, announced that its board of directors has appointed AVIA President Linda Finkel to...

Goldfinch Bio Presents Clinical Data from Phase 1 Trial Supporting Advancement of GFB-887 as a Precision Medicine for Patients with Kidney Diseases

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced...

U.S. Food and Drug Administration Approves Gilead’s Antiviral Veklury® (remdesivir) for Treatment of COVID-19

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved the antiviral drug Veklury®...